Recruiting Retinitis Pigmentosa Studies in Denver
About Retinitis Pigmentosa Clinical Trials in Denver
Retinitis pigmentosa (RP) is a group of inherited retinal diseases that cause progressive loss of photoreceptor cells in the retina, leading to vision loss. It typically begins with night blindness and progresses to tunnel vision. Gene therapy and retinal implants are areas of active research.
There are currently 2 retinitis pigmentosa clinical trials recruiting participants in Denver, CO. These studies are seeking a combined 318 participants. Research is being sponsored by R1 Therapeutics, Takeda. Clinical trial participation is free and participants receive study-related medical care at no cost.
Retinitis Pigmentosa Clinical Trials in Denver — FAQ
Are there retinitis pigmentosa clinical trials in Denver?
Yes, there are 2 retinitis pigmentosa clinical trials currently recruiting in Denver, CO. Browse the studies on this page to find one that fits.
How do I join a clinical trial in Denver?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Denver research site will contact you about next steps.
Are clinical trials in Denver free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Denver studies also compensate for your time and travel.
What retinitis pigmentosa treatments are being tested?
The 2 active trials in Denver are testing new therapies including novel drugs, biologics, and treatment approaches for retinitis pigmentosa.
Data updated July 13, 2026 from ClinicalTrials.gov